On-Chip Replication of Extremely Early-Stage Tumor Behavior

Area of Science:

• Oncology
• Biotechnology
• Microfluidics

Background:

• Cancer progression involves tumor growth, invasion, and metastasis.
• Extremely early-stage (EES) tumor progression is difficult to study due to small tumor size.
• Understanding EES tumor behavior is crucial for early diagnosis and effective therapy.

Purpose of the Study:

• To replicate and investigate tumor progression at the EES using a microfluidic chip.
• To uncover how the tumor microenvironment influences tumor behaviors at the EES.
• To provide insights into early-stage tumor development and potential therapeutic strategies.

Main Methods:

• Developed a microfluidic chip to mimic EES tumor progression.
• Seeded and cultured HeLa cell spheroids within a microvascular network.
• Analyzed tumor spheroid growth, cell behavior, and peritumoral angiogenesis under varying conditions.

Main Results:

• Demonstrated tumor progression at the EES on a microfluidic platform.
• Found that smaller tumors exhibit more aggressive behavior.
• Observed that endotheliocytes and fibroblasts accelerate tumor cell proliferation and migration.
• Documented dynamic epithelial-mesenchymal transition and vasculogenic mimicry at the EES.

Conclusions:

• Microfluidic models can effectively study EES tumor progression.
• The tumor microenvironment plays a critical role in early cancer development.
• Findings offer novel perspectives for developing EES tumor therapies.